MedTrace Logo

Effect of Fish Oil on Insulin Sensitivity

NCT01241474 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2012-08-07

No results posted yet for this study

Summary

The purpose of this study is to determine whether a prolonged (9 month) high (6g/d) of marine oil improves insulin sensitivity and glucose control in subjects with impaired glucose regulation.

Conditions

Interventions

DIETARY_SUPPLEMENT

EPAX 6000 (marine omega 3 EPA/DHA fatty acid concentrates

6 x 1g capsules per day of marine oil (contains 3g/d docosahexaenoic acid plus eicosapentaenoic acid) for a 9 month period

DIETARY_SUPPLEMENT

Maize (corn) oil

6 x 1g capsules per day for 9 months

Sponsors & Collaborators

  • University of Aberdeen

    lead OTHER

Principal Investigators

  • Gerald E Lobley, BSc PhD · Rowett Institute of Nutrition and Health, University of Aberdeen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01241474 on ClinicalTrials.gov